Choice's forecast indicates significant earnings growth for Park Medi World, expecting revenue to rise from ₹16.8 billion in FY26 to ₹39.4 billion by FY29, with stable EBITDA margins of 26.5%. The brokerage maintains a 'BUY' rating and sets a target price of ₹350.
Choice's forecast indicates significant earnings growth for Park Medi World, expecting revenue to rise from ₹16.8 billion in FY26 to ₹39.4 billion by FY29, with stable EBITDA margins of 26.5%. The brokerage maintains a 'BUY' rating and sets a target price of ₹350.
<iframe src="https://hindustansphere.com/embed/cluster/8889971f6c97119cd0f22979eb5e2078760ddc0c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Stocks to buy: Choice Broking sees 20% upside in this healthcare stock. Should you buy?"></iframe>
